MARKET

CPRX

CPRX

Catalyst Pharmaceuticals Inc
NASDAQ
22.76
-0.70
-2.98%
After Hours: 22.60 -0.16 -0.70% 19:58 05/08 EDT
OPEN
23.17
PREV CLOSE
23.46
HIGH
23.17
LOW
20.80
VOLUME
2.68M
TURNOVER
--
52 WEEK HIGH
26.16
52 WEEK LOW
14.47
MARKET CAP
2.78B
P/E (TTM)
17.35
1D
5D
1M
3M
1Y
5Y
1D
Catalyst Pharmaceuticals Reports Robust Growth in Earnings Call
TipRanks · 2h ago
Catalyst pharmaceuticals reaffirms 2025 revenue guidance of $545M-$565M with strong FIRDAPSE and AGAMREE performance
Seeking Alpha · 11h ago
Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y
NASDAQ · 12h ago
Analysts Are Bullish on These Healthcare Stocks: Establishment Labs Holdings (ESTA), Catalyst Pharma (CPRX)
TipRanks · 14h ago
Catalyst Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters · 1d ago
Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates
NASDAQ · 1d ago
Catalyst Pharmaceuticals backs FY25 revenue view $545M-$565M, consensus $557.23M
TipRanks · 1d ago
Catalyst Pharmaceuticals reports Q1 EPS 68c, consensus 53c
TipRanks · 1d ago
More
About CPRX
More
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.
Recently
Symbol
Price
%Change

Webull offers Catalyst Pharmaceuticals Inc stock information, including NASDAQ: CPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPRX stock methods without spending real money on the virtual paper trading platform.